OVERSEA CHINESE BANKING Corp Ltd Has $35.73 Million Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

OVERSEA CHINESE BANKING Corp Ltd boosted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 2.1% in the fourth quarter, Holdings Channel reports. The firm owned 265,954 shares of the medical research company’s stock after purchasing an additional 5,561 shares during the period. Agilent Technologies accounts for 1.0% of OVERSEA CHINESE BANKING Corp Ltd’s investment portfolio, making the stock its 24th biggest holding. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Agilent Technologies were worth $35,728,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. GSA Capital Partners LLP bought a new position in Agilent Technologies during the third quarter worth about $499,000. Natixis Advisors LLC grew its position in shares of Agilent Technologies by 15.7% in the 3rd quarter. Natixis Advisors LLC now owns 113,991 shares of the medical research company’s stock valued at $16,926,000 after purchasing an additional 15,435 shares during the period. Mutual of America Capital Management LLC increased its stake in Agilent Technologies by 0.3% during the 3rd quarter. Mutual of America Capital Management LLC now owns 50,306 shares of the medical research company’s stock worth $7,469,000 after purchasing an additional 160 shares in the last quarter. Thrivent Financial for Lutherans raised its holdings in Agilent Technologies by 3.1% during the 3rd quarter. Thrivent Financial for Lutherans now owns 292,789 shares of the medical research company’s stock worth $43,473,000 after buying an additional 8,874 shares during the period. Finally, Quest Partners LLC boosted its holdings in shares of Agilent Technologies by 339.3% in the third quarter. Quest Partners LLC now owns 6,862 shares of the medical research company’s stock valued at $1,019,000 after buying an additional 5,300 shares during the period.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Rodney Gonsalves sold 1,908 shares of the business’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares in the company, valued at approximately $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Barclays upgraded shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their price objective for the stock from $135.00 to $145.00 in a report on Monday, February 10th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Robert W. Baird cut their target price on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research note on Thursday, February 27th. Citigroup lifted their price objective on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Finally, Wells Fargo & Company decreased their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $146.15.

Agilent Technologies Stock Performance

NYSE:A opened at $123.10 on Wednesday. The stock’s 50-day moving average is $137.70 and its 200-day moving average is $137.68. Agilent Technologies, Inc. has a 1-year low of $117.17 and a 1-year high of $155.35. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56. The stock has a market cap of $35.09 billion, a P/E ratio of 28.30, a price-to-earnings-growth ratio of 3.44 and a beta of 1.11.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a $0.248 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.81%. Agilent Technologies’s dividend payout ratio is currently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.